Corbus Pharmaceuticals Holdings (CRBP) announced the appointment of Leonardo Viana Nicacio as Chief Medical Officer.
Nicacio brings over 20 years of pharmaceutical and oncology experience, notably serving as VP of Clinical Development at Seagen, where he led the advancement of the blockbuster Nectin-4 targeted